atorvastatin calcium

Generic: atorvastatin calcium

Labeler: aphena pharma solutions - tennessee, llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name atorvastatin calcium
Generic Name atorvastatin calcium
Labeler aphena pharma solutions - tennessee, llc
Dosage Form TABLET, FILM COATED
Routes
ORAL
Active Ingredients

atorvastatin calcium trihydrate 40 mg/1

Manufacturer
Aphena Pharma Solutions - Tennessee, LLC

Identifiers & Regulatory

Product NDC 71610-163
Product ID 71610-163_505bc442-3fe2-427f-89d9-3057dc391b38
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA205519
Listing Expiration 2026-12-31
Marketing Start 2017-11-16

Pharmacologic Class

Classes
hmg-coa reductase inhibitor [epc] hydroxymethylglutaryl-coa reductase inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 71610163
Hyphenated Format 71610-163

Supplemental Identifiers

RxCUI
617311
UNII
48A5M73Z4Q

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name atorvastatin calcium (source: ndc)
Generic Name atorvastatin calcium (source: ndc)
Application Number ANDA205519 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 40 mg/1
source: ndc
Packaging
  • 15 TABLET, FILM COATED in 1 BOTTLE (71610-163-15)
  • 30 TABLET, FILM COATED in 1 BOTTLE (71610-163-30)
  • 45 TABLET, FILM COATED in 1 BOTTLE (71610-163-45)
source: ndc

Packages (3)

Ingredients (1)

atorvastatin calcium trihydrate (40 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "505bc442-3fe2-427f-89d9-3057dc391b38", "openfda": {"unii": ["48A5M73Z4Q"], "rxcui": ["617311"], "spl_set_id": ["ed8e76a5-6b40-47fe-9018-25bfe690a4dd"], "manufacturer_name": ["Aphena Pharma Solutions - Tennessee, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "15 TABLET, FILM COATED in 1 BOTTLE (71610-163-15)", "package_ndc": "71610-163-15", "marketing_start_date": "20181001"}, {"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (71610-163-30)", "package_ndc": "71610-163-30", "marketing_start_date": "20181001"}, {"sample": false, "description": "45 TABLET, FILM COATED in 1 BOTTLE (71610-163-45)", "package_ndc": "71610-163-45", "marketing_start_date": "20181001"}], "brand_name": "ATORVASTATIN CALCIUM", "product_id": "71610-163_505bc442-3fe2-427f-89d9-3057dc391b38", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["HMG-CoA Reductase Inhibitor [EPC]", "Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]"], "product_ndc": "71610-163", "generic_name": "ATORVASTATIN CALCIUM", "labeler_name": "Aphena Pharma Solutions - Tennessee, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ATORVASTATIN CALCIUM", "active_ingredients": [{"name": "ATORVASTATIN CALCIUM TRIHYDRATE", "strength": "40 mg/1"}], "application_number": "ANDA205519", "marketing_category": "ANDA", "marketing_start_date": "20171116", "listing_expiration_date": "20261231"}